Systemic thymulin overexpression mitigates cognitive and molecular impairments in a rat model of sporadic Alzheimer’s Disease
Facundo Peralta, Ana Abril Vidal Escobedo, Juliette López Hanotte, Joaquín Pardo, Paula Cecilia Reggiani · 2025
Read Systemic thymulin overexpression mitigates cognitive and molecular impairments in a rat model of sporadic Alzheimer’s Disease by Facundo Peralta, Ana Abril Vidal Escobedo, Juliette López Hanotte, Joaquín Pardo, Paula Cecilia Reggiani (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710224.txt.
Description
Facundo Peralta and co-workers test thymulin gene therapy in a rat model of sporadic Alzheimer's disease, in a 2025 paper. Thymulin is a thymus peptide with anti-inflammatory effects. The disease model uses a single brain injection of a toxin that impairs memory and behavior.
Rats received a viral vector that raised thymulin levels across the body, given into muscle at two time points. Treated rats behaved much like healthy controls on exploration, anxiety, and mood tests. Recognition memory, impaired in untreated model rats, was restored. At the tissue level, some brain cell effects of the toxin were not reversed. The authors report a partial benefit.
Catalog record
| CREATOR | Facundo Peralta, Ana Abril Vidal Escobedo, Juliette López Hanotte, Joaquín Pardo, Paula Cecilia Reggiani |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |